Ignite Creation Date:
2025-12-25 @ 2:31 AM
Ignite Modification Date:
2026-01-25 @ 3:35 PM
Study NCT ID:
NCT02095834
Status:
COMPLETED
Last Update Posted:
2021-01-11
First Post:
2014-03-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Carfilzomib, Bendamustine Hydrochloride, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-04-24
Start Date Type:
ACTUAL
Primary Completion Date:
2021-01-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-01-07
Completion Date Type:
ACTUAL
First Submit Date:
2014-03-21
First Submit QC Date:
None
Study First Post Date:
2014-03-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-07
Last Update Post Date:
2021-01-11
Last Update Post Date Type:
ACTUAL